Silas Inman


Orally Dissolving Rimegepant Rapidly Lowers Pain, Improves Symptoms for Acute Migraine

May 07, 2019

A 75 mg orally dissolving tablet formulation of the calcitonin gene-related peptide receptor antagonist met both co-primary end points of freedom from the patient-indicated most bothersome symptom and freedom from pain at 2 hours.